SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-046074
Filing Date
2017-08-31
Accepted
2017-08-31 10:17:49
Documents
3
Period of Report
2017-08-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v474440_8k.htm 8-K 17233
2 EXHIBIT 99.1 v474440_ex99-1.htm EX-99.1 13908
3 GRAPHIC image_001.jpg GRAPHIC 4409
  Complete submission text file 0001144204-17-046074.txt   38632
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15070 | Film No.: 171062328
SIC: 2834 Pharmaceutical Preparations